ThermoFisherScientific - Custom and Bulks
Pharma Focus Europe
Worldwide Clinical Trials - Neuroscience Clinical Development

Hoth Therapeutics and Wise Systems International SRL Form Alliance to Leverage AI in Drug Discovery

Tuesday, June 11, 2024

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a company dedicated to patient-focused biopharmaceutical solutions, announced a new partnership with Wise Systems International SRL. This collaboration will leverage Nvidia's BioNeMo AI platform. BioNeMo enables researchers and developers to efficiently build and integrate advanced generative AI applications throughout the entire drug discovery process, from target identification to lead optimization. With the support of SRL, Hoth Therapeutics aims to enhance its pipeline and increase the value of its assets.

Robert Antofe from Wise Systems International SRL expressed excitement about the partnership, stating, "We look forward to working with Hoth and using our AI expertise to bring value to both companies through Hoth Therapeutics' AI initiatives."

Hoth Therapeutics, remarked, "We believe the Nvidia BioNeMo platform is the best in its class. With the assistance of SRL, we can further develop our intellectual property, optimize our current pipeline, and deliver innovative therapeutics to patients in need."

 

Source: prnewswire.com

magazine-slider-img
Thermo Fisher Scientific viral vector services (VVS)ThermoFisher - Mastering API production at every scaleFuture Labs Live - 2024World Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva